INSIDER · CIK 1055951
Orbimed Advisors LLC
Director, 10% Owner at ADARx Pharmaceuticals, Inc. (ADRX) · Director, 10% Owner at Electra Therapeutics, Inc. (ETRA) · Director at BlossomHill Therapeutics, Inc. (BLSM) · Director, 10% Owner at Braveheart Bio, Inc. (BRVE)
↗8 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$81.1MBought on the market
$0.00Sold on the market
4Companies
Sep 30, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 202617:23 | Sep 28, 2026 | ADRXADARx Pharmaceuticals, Inc. | Director, 10% Owner | P · Buy | $17.00 | +950,000 | 588,235 | — | +$16.1M | -12.1% | +5.0% |
| Sep 30, 202617:23 | Sep 28, 2026 | ADRXADARx Pharmaceuticals, Inc. | Director, 10% Owner | C · Convert | — | +23,255,789 | 9,230,509 | — | — | ||
| Sep 23, 202617:29 | Sep 21, 2026 | ETRAElectra Therapeutics, Inc. | Director, 10% Owner | P · Buy | $15.00 | +1,333,333 | 1,758,279 | +314% | +$20.0M | +13.2% | -42.4% |
| Sep 23, 202617:29 | Sep 21, 2026 | ETRAElectra Therapeutics, Inc. | Director, 10% Owner | C · Convert | — | +5,551,837 | 758,279 | — | — | ||
| Aug 12, 202616:43 | Aug 10, 2026 | BLSMBlossomHill Therapeutics, Inc. | Director | P · Buy | $16.00 | +625,000 | 2,714,279 | +30% | +$10.0M | 0.0% | -4.9% |
| Aug 12, 202616:43 | Aug 10, 2026 | BLSMBlossomHill Therapeutics, Inc. | Director | C · Convert | — | +2,089,279 | 2,089,279 | New | — | ||
| Aug 11, 202617:27 | Aug 7, 2026 | BRVEBraveheart Bio, Inc. | Director, 10% Owner | P · Buy | $18.00 | +1,940,000 | 273,333 | — | +$34.9M | -39.6% | +17.7% |
| Aug 11, 202617:27 | Aug 7, 2026 | BRVEBraveheart Bio, Inc. | Director, 10% Owner | C · Convert | — | +9,132,420 | 10,235,159 | +828% | — |